1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Late Stage Chronic Kidney Disease Drugs Market – By Product Type
1.3.2 Late Stage Chronic Kidney Disease Drugs Market – By Indication
1.3.3 Late Stage Chronic Kidney Disease Drugs Market – By Distribution Channel
1.3.4 Late Stage Chronic Kidney Disease Drugs Market – By Geography
2. Late Stage Chronic Kidney Disease Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Late Stage Chronic Kidney Disease Drugs Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia-Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South & Central America (SCAM) – PEST Analysis
4.3 Expert Opinion
5. Late Stage Chronic Kidney Disease Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Diseases Leading to Chronic Kidney Diseases
5.1.2 Favourable Reimbursement Policy for the Late Stage Chronic Kidney Disease Drugs
5.2 Market Restraints
5.2.1 Delay in the Diagnosis of Chronic Kidney Disease
5.3 Market Opportunities
5.3.1 Introduction of New Late Stage Chronic Kidney Disease Drugs
5.4 Future Trends
5.4.1 Introduction of New Preclinical Models to Improve Target Validation and Understand Disease Development
5.5 Impact Analysis
6. Late Stage Chronic Kidney Disease Drugs Market – Global Analysis
6.1 Global Late Stage Chronic Kidney Disease Drugs Market Revenue Forecast And Analysis
6.2 Global Late Stage Chronic Kidney Disease Drugs Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Late Stage Chronic Kidney Disease Drugs Market Analysis – By Product Type
7.1 Overview
7.2 Late Stage Chronic Kidney Disease Drugs Market Revenue Share, by Late Stage Chronic Kidney Disease Drugs by Product Type (2019 and 2027)
7.3 Calcimimetics
7.3.1 Overview
7.3.2 Calcimimetics: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamin D
7.4.1 Overview
7.4.2 Vitamin D: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Potassium Binders
7.5.1 Overview
7.5.2 Potassium Binders: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Calcium-Based Phosphate Binders
7.6.1 Calcium-Based Phosphate Binders: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Others
7.7.1 Others: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
8. Late Stage Chronic Kidney Disease Drugs Market Analysis By Indication
8.1 Overview
8.2 Late Stage Chronic Kidney Disease Drugs Market Revenue Share, by Indication (2019 and 2027)
8.3 Late Stage Chronic Kidney Disease Induced Hyperparathyroidism
8.3.1 Overview
8.3.2 Late Stage Chronic Kidney Disease Induced Hyperparathyroidism: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Late Stage Chronic Kidney Disease Induced Hyperphosphatemia
8.4.1 Overview
8.4.2 Late Stage Chronic Kidney Disease Induced Hyperphosphatemia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Late Stage Chronic Kidney Disease Induced Hyperkalemia
8.5.1 Overview
8.5.2 Late Stage Chronic Kidney Disease Induced Hyperkalemia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9. Late Stage Chronic Kidney Disease Drugs Market Analysis By Distribution Channel
9.1 Overview
9.2 Late Stage Chronic Kidney Disease Drugs Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Retail Pharmacies
9.5.1 Overview
9.5.2 Retail Pharmacies Segment : Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (US$ Million)
10. Late Stage Chronic Kidney Disease Drugs Market Analysis And Forecasts To 2027 – Geographical Analysis
10.1 North America: Late Stage Chronic Kidney Disease Drugs Market
10.1.1 Overview
10.1.2 North America: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America: Late Stage Chronic Kidney Disease Drugs Market, By Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Late Stage Chronic Kidney Disease Drugs Market, by Country, 2019 & 2027 (%)
10.1.7 US: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Late Stage Chronic Kidney Disease Drugs Market
10.2.1 Overview
10.2.2 Europe: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Late Stage Chronic Kidney Disease Drugs Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.8 France: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 France: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 France: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 France: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 France: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.9 UK: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 UK: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 UK: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 UK: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 UK: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.10 Italy: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Italy: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Italy: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Italy: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Italy: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.11 Spain: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Spain: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Spain: Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Spain: Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Spain: Late Stage Chronic Kidney Disease Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3 Asia-Pacific: Late Stage Chronic Kidney Disease Drugs Market
10.3.1 Overview
10.3.2 Asia-Pacific: Late Stage Chronic Kidney Disease Drugs Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia-Pacific: Late Stage Chronic Kidney Disease Drugs Market, by Country, 2019 & 2027 (%)
10.4.1 China: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.1.1 China: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.1.2 China Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.4.1.3 China Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.1.4 China Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.2 Japan: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.2.1 Japan: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.2.2 Japan Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.4.2.3 Japan Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.2.4 Japan Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.3 India: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.3.1 India: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.3.2 India Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.4.3.3 India Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.3.4 India Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.4 South Korea: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.4.1 South Korea: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.4.2 South Korea Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.4.4.3 South Korea Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.4.4 South Korea Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.5 Australia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.5.1 Australia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.4.5.2 Australia Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.4.5.3 Australia Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.5.4 Australia Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.5 Middle East & Africa: Late Stage Chronic Kidney Disease Drugs Market
10.5.1 Overview
10.5.2 Middle East & Africa: Late Stage Chronic Kidney Disease Drugs Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
10.5.4 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market, by Indication– Revenue and Forecast to 2027 (USD Million)
10.5.5 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
10.5.6 Middle East & Africa: Late Stage Chronic Kidney Disease Drugs Market, by Country, 2019& 2027 (%)
10.5.7 Saudi Arabia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Saudi Arabia: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Saudi Arabia Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Saudi Arabia Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Saudi Arabia Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
10.5.8 UAE: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 UAE: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 UAE Late Stage Chronic Kidney Disease Drugs Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
10.5.8.3 UAE Late Stage Chronic Kidney Disease Drugs Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
10.5.8.4 UAE Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
10.5.9 South Africa: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.1 South Africa: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.2 South Africa Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.5.9.3 South Africa Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.5.9.4 South Africa Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
10.6 South and Central America: Late Stage Chronic Kidney Disease Drugs Market
10.6.1 Overview
10.6.2 South and Central America: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.6.3 South and Central America Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.6.4 South and Central America Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.6.5 South and Central America Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
10.6.6 South and Central America: Late Stage Chronic Kidney Disease Drugs Market, by Country, 2019 & 2027 (%)
10.6.7 Brazil: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.6.7.1 Brazil: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.6.7.2 Brazil Late Stage Chronic Kidney Disease Drugs Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
10.6.7.3 Brazil Late Stage Chronic Kidney Disease Drugs Market, by Indication– Revenue and Forecast to 2027 (USD Million)
10.6.7.4 Brazil Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
10.6.8 Argentina: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.6.8.1 Argentina: Late Stage Chronic Kidney Disease Drugs Market – Revenue and Forecast to 2027 (USD Million)
10.6.8.2 Argentina Late Stage Chronic Kidney Disease Drugs Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
10.6.8.3 Argentina Late Stage Chronic Kidney Disease Drugs Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.6.8.4 Argentina Late Stage Chronic Kidney Disease Drugs Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
11. Impact of COVID-19 Pandemic on Global Late Stage Chronic Kidney Disease Drugs Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Late Stage Chronic Kidney Disease Drugs Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 AbbVie Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Amgen
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 AstraZeneca
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Kyowa Kirin Co., Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Takeda Pharmaceutical Company Limited
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Astellas Pharma Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bayer AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Vifor Pharma Management Ltd.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Akebia Therapeutics, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms